Gary L Cook

US Patent:

8478116, Jul 2, 2013

Filed:

Aug 18, 2009

Appl. No.:

12/542834

Inventors:

Sam W. Henry - Ogden UT, US
Paul Neilson - Pleasant View UT, US
Gary Cook - Plain City UT, US

Assignee:

Chromalox, Inc. - Pittsburgh PA

International Classification:

F24H 1/20

US Classification:

392453, 392441, 392455, 392497

Abstract:

Disclosed is a heating unit which can comprise a tube, or pipe, having an aperture therein which can be configured to receive a heating element. In various embodiments, the heating element can comprise a resistive element which can be configured to generate heat when a voltage differential is applied thereto. In certain embodiments, the heating unit can further comprise a collar which is threadably engaged with the tube, wherein a flame path, or exhaust path, can be defined between threads on the pipe and threads on the collar, for example. In certain embodiments, the flame path can comprise a passageway defined between the circumference, or perimeter, of the tube and the collar. Such a flame path can be configured to allow pressurized gasses to safely escape from the tube along a predetermined path.

US Patent:

20060228414, Oct 12, 2006

Filed:

Jul 15, 2004

Appl. No.:

10/564494

Inventors:

Gary Cook - Longmont CO, US

Assignee:

PR Phamaceuticals, Inc - Fort Collins CO

International Classification:

A61K 48/00
A61K 38/28
A61K 38/09
A61K 38/11
A61K 9/26
A61K 31/70

US Classification:

424469000, 514015000, 514044000, 977906000, 514002000, 514003000, 514009000, 514023000

Abstract:

The methods disclosed herein are of use for the production of controlled release compositions. In particular, the methods provide the contacting of an organic phase containing a bioactive agent and a polymer with an aqueous phase containing an organic ion to create controlled release compositions containing bioactive agents. The present invention also includes controlled release compositions including a polymer, an organic ion and a bioactive agent. The present invention also includes methods of using such controlled release compositions. The usefulness of the present invention is that the methods result in the production of controlled release compositions containing bioactive agent capable of administration in a concentrated low-dose form, having low burst and reduced production of degraded bioactive agent.

US Patent:

20070092574, Apr 26, 2007

Filed:

Jul 15, 2004

Appl. No.:

10/565401

Inventors:

Gary Cook - Longmont CO, US

Assignee:

PR PHARMACEUTICALS, INC. - FORT COLLINS CO

International Classification:

A61K 48/00
A61K 38/22
A61K 38/12
A61K 38/09
A61K 31/715
A61K 9/14

US Classification:

424489000, 514012000, 514009000, 514015000, 514044000, 514054000, 977906000

Abstract:

The compositions disclosed herein are for use as controlled release therapeutics for the treatment of a wide variety of diseases. In particular, the compositions provide water soluble bioactive agents, organic ions and polymers where the bioactive agent is efficiently released over time with minimal degradation products. The resulting controlled release composition is capable of administration in a decreased dose volume due to the high drug content and predominance of non-degraded bioactive agent after release. Additionally, the compositions, of the present invention are capable of long term, sustained releases.

US Patent:

20070292475, Dec 20, 2007

Filed:

Dec 1, 2006

Appl. No.:

11/607382

Inventors:

Kathleen Campbell - Longmont CO, US
Pericles Calias - Melrose MA, US
Gary Cook - Westford MA, US
Mary Ganley - Norwood MA, US

International Classification:

A61K 9/52
A61P 27/02

US Classification:

424428000, 424489000

Abstract:

Formulations for controlled, sustained release of biologically active agents for the treatment of ocular disorders have been developed. These formulations are based on solid microparticles formed of the combination of biodegradable, synthetic polymers such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and copolymers thereof. The microparticles are characterized by low burst levels and efficient drug loading and sustained release.

US Patent:

20100143485, Jun 10, 2010

Filed:

Mar 5, 2004

Appl. No.:

10/547958

Inventors:

Paul S. Hudnut - Fort Collins CO, US
Gary P. Cook - Westford MA, US

International Classification:

A61K 9/50
A61K 38/22
A61P 15/00
A61P 25/00

US Classification:

424497, 514 2

Abstract:

The compositions disclosed herein are of use for the treatment of a wide variety of diseases. In particular, the compositions provide oxytocin and oxytocin analogs in sustained release formulations. In particular embodiments, the disclosed compositions concern oxytocin and oxytocin analogs, each of which may be associated with a biodegradable polymer and/or attached to a hydrophilic polymer. The methods include treatment of a wide variety of diseases and conditions. In particular, the methods include treatment of sexual dysfunction and disorders associated with repetitive behaviors, such as autism. The usefulness of the present invention is that the oxytocin, oxytocin analogs and mixtures thereof can be administered in a pharmaceutical formulation that increases their half-life and also provides for sustained release.